Crossref
journal-article
Elsevier BV
Cancer Letters (78)
References
69
Referenced
138
10.3322/canjclin.50.1.7
/ CA Cancer J. Clin. / Cancer statistics by Greenlee (2000){'key': '10.1016/S0304-3835(02)00413-5_BIB2', 'series-title': "Campbell's Urology", 'first-page': '1381', 'article-title': 'The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles', 'author': 'Martin', 'year': '1998'}
/ Campbell's Urology / The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles by Martin (1998){'key': '10.1016/S0304-3835(02)00413-5_BIB3', 'series-title': 'The Endocrine Function of the Testis', 'first-page': '157', 'article-title': 'The physical state of testosterone in plasma', 'author': 'Vermeulen', 'year': '1973'}
/ The Endocrine Function of the Testis / The physical state of testosterone in plasma by Vermeulen (1973)10.1210/jc.86.8.3467
/ J. Clin. Endocrinol. Metab. / The endocrinology of prostate cancer by Taplin (2001)10.1016/S0083-6729(08)61151-6
/ Vitam. Horm. / Molecular mechanisms of androgen action by Lindzey (1994){'key': '10.1016/S0304-3835(02)00413-5_BIB6', 'first-page': '191', 'article-title': 'Intermittent androgen suppression for prostate cancer: Canadian prospective trial and related observations', 'volume': '4', 'author': 'Bruchovsky', 'year': '2000', 'journal-title': 'Mol. Urol.'}
/ Mol. Urol. / Intermittent androgen suppression for prostate cancer: Canadian prospective trial and related observations by Bruchovsky (2000)10.1016/S0090-4295(01)01347-4
/ Urology / Salpha-reductase inhibitors: what role should they play by Kaplan (2001)10.1677/erc.0.0060131
/ Endocr. Relat. Cancer / Local estrogen biosynthesis in males and females by Simpson (1999){'key': '10.1016/S0304-3835(02)00413-5_BIB9', 'first-page': '213', 'article-title': 'Role of estrogens in human benign prostatic hyperplasia', 'volume': '3', 'author': 'Sciarra', 'year': '2000', 'journal-title': 'Arch. Androl.'}
/ Arch. Androl. / Role of estrogens in human benign prostatic hyperplasia by Sciarra (2000)10.1210/edrv-17-6-587
/ Endocr. Rev. / Interaction of steroid hormone receptors with the transcription initiation complex by Beato (1996)10.3109/07435809609030508
/ Endocr. Res. / Androgen receptor phosphorylation by Blok (1996)10.1042/bj2910095
/ Biochem. J. / Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor by Kuiper (1993)10.1093/jnci/93.22.1687
/ J. Natl Cancer Inst. / Androgen receptor signaling in androgen-refractory prostate cancer by Grossmann (2001)10.1002/1097-0142(19811115)48:10<2267::AID-CNCR2820481023>3.0.CO;2-R
/ Cancer / Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations by Ahluwalia (1981)10.1016/0091-7435(80)90037-7
/ Prev. Med. / Environmental factors, hormone status, and prostatic cancer by Hill (1980)10.1093/ajcn/33.5.1010
/ Am. J. Clin. Nutr. / Plasma hormones and lipids in men at different risk for coronary heart disease by Hill (1980){'key': '10.1016/S0304-3835(02)00413-5_BIB17', 'first-page': '45', 'article-title': 'Serum testosterone levels in healthy young black and white men', 'volume': '1', 'author': 'Ross', 'year': '1986', 'journal-title': 'J. Natl Cancer Inst.'}
/ J. Natl Cancer Inst. / Serum testosterone levels in healthy young black and white men by Ross (1986)10.1038/bjc.1988.46
/ Br. J. Cancer / The early in utero estrogen and testosterone environment of blacks and whites: potential effects on male offspring by Henderson (1988){'key': '10.1016/S0304-3835(02)00413-5_BIB19', 'first-page': '3445', 'article-title': 'Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch–Japanese case–control study', 'volume': '51', 'author': 'de Jong', 'year': '1991', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch–Japanese case–control study by de Jong (1991)10.1016/0140-6736(92)90927-U
/ Lancet / 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males by Bernstein (1992){'key': '10.1016/S0304-3835(02)00413-5_BIB21', 'first-page': '735', 'article-title': 'Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada', 'volume': '4', 'author': 'Wu', 'year': '1995', 'journal-title': 'Cancer Epidemiol. Biomarkers Prev.'}
/ Cancer Epidemiol. Biomarkers Prev. / Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada by Wu (1995)10.1016/0039-128X(92)90032-5
/ Steroids / Racial/Ethnic variations in male testosterone levels: a probable contributor to group differences in health by Ellis (1992){'key': '10.1016/S0304-3835(02)00413-5_BIB23', 'first-page': '1020', 'article-title': 'A prevalent missense substitution that modulates activity of prostatic steroid 5-alpha-reductase', 'volume': '57', 'author': 'Makridakis', 'year': '1997', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / A prevalent missense substitution that modulates activity of prostatic steroid 5-alpha-reductase by Makridakis (1997)10.1210/jc.83.6.2104
/ J. Clin. Endocrinol. Metab. / Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects by Santner (1998)10.1056/NEJM199810083391504
/ N. Engl. J. Med. / Bilateral Orchiectomy with or without Flutamide for metastatic prostate cancer by Eisenberg (1998)10.3322/canjclin.52.3.154
/ CA Cancer J. Clin. / The current state of hormonal therapy for prostate cancer by Hellerstedt (2002)10.1210/jc.84.10.3463
/ J. Clin. Endocrinol. Metab. / Hormonal signaling in prostatic hyperplasia and neoplasia by Marcelli (1999)10.1007/s002400000111
/ Urol. Res. / Androgen receptor an update of mechanism of action in prostate cancer by Culig (2000)10.1016/S0022-5347(17)37389-5
/ J. Urol. / Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate by Chodak (1992)10.1007/BF02738167
/ Cell Biochem. Biophys. / Intracellular localization and trafficking of steroid receptors by Baumann (1999){'key': '10.1016/S0304-3835(02)00413-5_BIB31', 'first-page': '4096', 'article-title': 'Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis', 'volume': '54', 'author': 'Tilley', 'year': '1994', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis by Tilley (1994){'key': '10.1016/S0304-3835(02)00413-5_BIB32', 'first-page': '1008', 'article-title': 'Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells', 'volume': '62', 'author': 'Zegarra-moro', 'year': '2002', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells by Zegarra-moro (2002){'key': '10.1016/S0304-3835(02)00413-5_BIB33', 'first-page': '4111', 'article-title': 'Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes', 'volume': '57', 'author': 'Lu', 'year': '1997', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes by Lu (1997)10.1210/me.13.3.376
/ Mol. Endocrinol. / Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter by Lu (1999)10.1002/(SICI)1097-0045(19990401)39:1<8::AID-PROS2>3.0.CO;2-N
/ Prostate / Prognostic value and expression of p21 (wafl/cipl) protein in prostate cancer by Aaltomaa (1999){'key': '10.1016/S0304-3835(02)00413-5_BIB36', 'first-page': '5611', 'article-title': 'Androgen blocks apoptosis of hormone-dependent prostate cancer cells', 'volume': '61', 'author': 'Kimura', 'year': '2001', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Androgen blocks apoptosis of hormone-dependent prostate cancer cells by Kimura (2001)10.1210/me.7.12.1541
/ Mol. Endocrinol. / Mutant androgen receptor detected in advanced-stage prostate carcinoma is activated by adrenal androgens and progesterone by Culig (1993)10.1073/pnas.89.14.6319
/ Proc. Natl Acad. Sci. USA / Androgen receptor gene mutations in human prostate cancer by Newmark (1992)10.1056/NEJM199505253322101
/ N. Engl. J. Med. / Mutation of androgen-receptor gene in metastatic androgen-independent prostate cancer by Taplin (1995){'key': '10.1016/S0304-3835(02)00413-5_BIB40', 'first-page': '1937', 'article-title': 'The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer', 'volume': '55', 'author': 'Irvine', 'year': '1995', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer by Irvine (1995)10.1093/nar/22.15.3181
/ Nucleic Acids Res. / The length and location of CAG trinucleotide repeats in the androgen-receptor N-terminal domain affect transactivation function by Chamberlain (1994){'key': '10.1016/S0304-3835(02)00413-5_BIB42', 'first-page': '4497', 'article-title': 'Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility', 'volume': '58', 'author': 'Ross', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility by Ross (1998)10.1038/sj.ejhg.5200298
/ Eur. J. Hum. Genet. by Correa-Cerro (1999)10.1210/en.131.3.1571
/ Endocrinology / Structure of human type II 5-alpha-reductase gene by Labrie (1992)10.1093/hmg/2.6.820
/ Hum. Mol. Genet. / Unusual length polymorphism in human steroid 5-alpha-reductase type 2 gene (SRD5A2) by Davis (1993)10.1001/archsurg.1941.01210140043004
/ Arch. Surg. / Studies on prostatic cancer: the effects of castration on advanced carcinoma of the prostate gland by Huggins (1941)10.1159/000474179
/ Eur. Urol. / Androgen receptors in untreated and treated prostatic intraepithelial neoplasia by van der Kwast (1996)10.1002/(SICI)1097-0045(199602)28:2<129::AID-PROS9>3.0.CO;2-B
/ Prostate / Adrogen receptor status from lymph node metastases from prostate cancer by Hobisch (1996){'key': '10.1016/S0304-3835(02)00413-5_BIB49', 'first-page': '2577', 'article-title': 'Distant metastases from prostatic carcinoma express androgen receptor protein', 'volume': '55', 'author': 'Hobisch', 'year': '1995', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Distant metastases from prostatic carcinoma express androgen receptor protein by Hobisch (1995)10.1002/j.1875-9114.1996.tb02967.x
/ Pharmacotherapy / The mutated androgen receptor and its implications for the treatment of metastatic carcinoma of the prostate by Middleman (1996)10.1002/1097-0045(199609)29:3<153::AID-PROS2990290303>3.0.CO;2-5
/ Prostate / Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome by Suzuki (1996){'key': '10.1016/S0304-3835(02)00413-5_BIB52', 'first-page': '2511', 'article-title': 'Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist', 'volume': '59', 'author': 'Taplin', 'year': '1999', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist by Taplin (1999){'key': '10.1016/S0304-3835(02)00413-5_BIB53', 'first-page': '5474', 'article-title': 'Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor', 'volume': '54', 'author': 'Culig', 'year': '1994', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor by Culig (1994)10.1126/science.279.5350.563
/ Science / Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study by Chan (1998)10.1073/pnas.97.7.3455
/ Proc. Natl Acad. Sci. USA / Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice by Digioganni (2000){'key': '10.1016/S0304-3835(02)00413-5_BIB56', 'first-page': '5825', 'article-title': 'Ligand-independent activation of the androgen receptor by differentiation agent butyrate in human prostate cancer cells', 'volume': '60', 'author': 'Sadar', 'year': '2000', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Ligand-independent activation of the androgen receptor by differentiation agent butyrate in human prostate cancer cells by Sadar (2000)10.1083/jcb.150.4.873
/ J. Cell. Biol. / Cyclin E as a coactivator of the androgen receptor by Yamamoto (2000)10.1074/jbc.271.33.19900
/ J. Biol. Chem. / Activation of human androgen receptor through a protein kinase A pathway by Nazareth (1996){'key': '10.1016/S0304-3835(02)00413-5_BIB59', 'first-page': '4640', 'article-title': 'Interleukin-6 regulates prostate specific-protein expression in prostate carcinoma cells by activation of the androgen receptor', 'volume': '58', 'author': 'Hobisch', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Interleukin-6 regulates prostate specific-protein expression in prostate carcinoma cells by activation of the androgen receptor by Hobisch (1998)10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H
/ Prostate / Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer by Drachenberg (1999)10.1016/S0022-5347(01)62092-5
/ J. Urol. / Elevated levels of circulating interleukin-6 and transforming growth factor-beta 1 in patients with metastatic prostate cancer by Adler (1999)10.1074/jbc.M108255200
/ J. Biol. Chem. / Activation of androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways by Ueda (2002)10.1023/A:1015531326689
/ Cancer Metastasis Rev. / Contribution of the androgen receptor to prostate cancer predisposition and progression by Buchanan (2001)10.1038/35094009
/ Nat. Rev. Cancer / The development of androgen-independent prostate cancer by Feldman (2001){'key': '10.1016/S0304-3835(02)00413-5_BIB65', 'first-page': '3821', 'article-title': 'Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression', 'volume': '59', 'author': 'Cox', 'year': '1999', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression by Cox (1999)10.1016/0006-2952(90)90276-Q
/ Biochem. Pharmacol. / Serotonin as a growth factor by Seuwen (1990)10.1023/A:1012407027175
/ Ann. Oncol. / Neuroendocrine pathogenesis in adenocarcinoma of the prostate by Hansson (2001)10.1046/j.1464-4096.2001.001223.x
/ BJU / Serum chromogranin-A in advanced prostate cancer by Ferrero-Pous (2001){'issue': 'March', 'key': '10.1016/S0304-3835(02)00413-5_BIB69', 'volume': '43', 'author': 'Debes', 'year': '2002', 'journal-title': 'Proc. AACR'}
/ Proc. AACR by Debes (2002)
Dates
Type | When |
---|---|
Created | 22 years, 10 months ago (Oct. 8, 2002, 9:11 a.m.) |
Deposited | 1 year, 8 months ago (Jan. 6, 2024, 10:49 p.m.) |
Indexed | 35 minutes ago (Sept. 7, 2025, 6:25 p.m.) |
Issued | 22 years, 9 months ago (Dec. 1, 2002) |
Published | 22 years, 9 months ago (Dec. 1, 2002) |
Published Print | 22 years, 9 months ago (Dec. 1, 2002) |
@article{Debes_2002, title={The role of androgens and the androgen receptor in prostate cancer}, volume={187}, ISSN={0304-3835}, url={http://dx.doi.org/10.1016/s0304-3835(02)00413-5}, DOI={10.1016/s0304-3835(02)00413-5}, number={1–2}, journal={Cancer Letters}, publisher={Elsevier BV}, author={Debes, Jose D and Tindall, Donald J}, year={2002}, month=dec, pages={1–7} }